Thanks to all @IMI_ERA4TB WP2 meeting participants (both in person and online) @unizar @ARAID_ES @amr_d2.
A great balance between constructive science and enjoyable interactions.
See you all next year @PasteurLille
📢Our November newsletter is out!
- news on IMI's successor, the Innovative Health Initiative
- new IMI projects on protein-based drugs, #RareDiseases, #AMR, #cancer & #AI
- project results on patient preferences, #Alzheimer, #Ebola, #DataQuality, #TB
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.